pI: 5.5562 |
Length (AA): 475 |
MW (Da): 54955 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
38 | 474 | 3ahq (A) | 34 | 464 | 49.00 | 0 | 1 | 1.2971 | -0.54 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127747)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G72280 | endoplasmic oxidoreductin-1 |
Arabidopsis thaliana | AT2G38960 | endoplasmic oxidoreductin-2 |
Babesia bovis | BBOV_IV002420 | endoplasmic reticulum oxidoreductin, putative |
Brugia malayi | Bm1_47995 | Endoplasmic Reticulum Oxidoreductin 1 |
Candida albicans | CaO19.4871 | protein disulfide bond formation in the ER |
Candida albicans | CaO19.12335 | protein disulfide bond formation in the ER |
Caenorhabditis elegans | CELE_Y105E8B.8 | Protein ERO-1, isoform B |
Cryptosporidium hominis | Chro.80371 | hypothetical protein |
Cryptosporidium parvum | cgd8_3190 | endoplasmic reticulum oxidoreductin |
Dictyostelium discoideum | DDB_G0288849 | hypothetical protein |
Drosophila melanogaster | Dmel_CG1333 | Endoplasmic reticulum oxidoreductin-1-like |
Echinococcus granulosus | EgrG_000245100 | Endoplasmic reticulum oxidoreductin 1 |
Echinococcus multilocularis | EmuJ_000245100 | Endoplasmic reticulum oxidoreductin 1 |
Homo sapiens | ENSG00000086619 | ERO1-like beta (S. cerevisiae) |
Homo sapiens | 30001 | ERO1-like (S. cerevisiae) |
Leishmania braziliensis | LbrM.16.1590 | endoplasmic reticulum oxidoreductin, putative |
Leishmania donovani | LdBPK_161630.1 | endoplasmic reticulum oxidoreductin, putative |
Leishmania infantum | LinJ.16.1630 | endoplasmic reticulum oxidoreductin, putative |
Leishmania major | LmjF.16.1530 | endoplasmic reticulum oxidoreductin, putative |
Leishmania mexicana | LmxM.16.1530 | endoplasmic reticulum oxidoreductin, putative |
Loa Loa (eye worm) | LOAG_00621 | hypothetical protein |
Mus musculus | ENSMUSG00000021831 | ERO1-like (S. cerevisiae) |
Mus musculus | ENSMUSG00000057069 | ERO1-like beta (S. cerevisiae) |
Neospora caninum | NCLIV_060300 | cDNA, FLJ96396, highly similar to Homo sapiens ERO1-like beta (S. cerevisiae) (ERO1LB), mRNA, related |
Oryza sativa | 4334011 | Os03g0733800 |
Plasmodium berghei | PBANKA_0924300 | endoplasmic reticulum oxidoreductin, putative |
Plasmodium falciparum | PF3D7_1124000 | endoplasmic reticulum oxidoreductin, putative |
Plasmodium knowlesi | PKNH_0921800 | endoplasmic reticulum oxidoreductin, putative |
Plasmodium vivax | PVX_091815 | endoplasmic reticulum oxidoreductin, putative |
Plasmodium yoelii | PY07009 | hypothetical protein |
Saccharomyces cerevisiae | YML130C | Ero1p |
Schistosoma japonicum | Sjp_0204470 | ko:K00391 ERO1-like [EC:1.8.4.-], putative |
Schistosoma mansoni | Smp_124920 | ero1-related |
Schmidtea mediterranea | mk4.001337.09 | Endoplasmic reticulum oxidoreductin-1 |
Trypanosoma brucei gambiense | Tbg972.8.4700 | endoplasmic reticulum oxidoreductin, putative,pol-associated gene 1 |
Trypanosoma brucei | Tb927.8.4890 | pol-associated gene 1 |
Trypanosoma congolense | TcIL3000_0_00060 | endoplasmic reticulum oxidoreductin, putative |
Trypanosoma cruzi | TcCLB.508837.189 | endoplasmic reticulum oxidoreductin, putative |
Toxoplasma gondii | TGME49_300380 | endoplasmic reticulum oxidoreductin, putative |
Theileria parva | TP03_0411 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.4890 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.4890 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.4890 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.4890 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y105E8B.8 | Caenorhabditis elegans | larval arrest | wormbase |
YML130C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_300380 | Toxoplasma gondii | Probably non-essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | ERO1-like (S. cerevisiae) | Compounds | References |